Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +0.84% | -14.96% | +1.76% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.28% | 88.93M | |
+18.95% | 125B | |
+14.17% | 108B | |
-3.49% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.48% | 16.54B | |
-12.05% | 16.5B | |
+3.08% | 13.39B | |
+27.98% | 11.1B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024